Fig. 3From: Individualised dosimetry and safety of SIRT for intrahepatic cholangiocarcinomaComparison of baseline Bilirubin measures in blood and baseline global liver uptake rate as measured by 99mTc-mebrofenin dynamic scintigraphyBack to article page